Shanghai Unicar-Therapy Bio-medicine Technology
PrivateLast Round
Series C
Aug 26, 2022
Total Funding Raised
$8.2M
Company Overview
Shanghai Unicar-Therapy Bio-medicine Technology is a biotechnology company that develops cellular immunotherapy drugs and CAR-T therapies for oncology treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai Unicar-Therapy Bio-medicine Technology Comparables
Compare Shanghai Unicar-Therapy Bio-medicine Technology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Juventas Cell Therapy Ltd. | 88% | |
| Shanghai YaKe Biotechnology Co., Ltd. | 88% | |
| Chongqing Precision Biotech Co., Ltd. | 88% |
Shanghai Unicar-Therapy Bio-medicine Technology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Aug 26, 2022 | ||||
| Series B | Mar 30, 2021 | ||||
| Series A | Jun 1, 2019 | ||||
| Angel | Mar 1, 2016 |
Shanghai Unicar-Therapy Bio-medicine Technology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alwin Capital | Series A |
| Junci Investment | Series C |
| Apricot Capital | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 26, 2022
Raised $4M with Junci Investment participating
- Jun 1, 2019
Raised Series A with Alwin Capital and Hainan Haiyao Co Ltd.
Shanghai Unicar-Therapy Bio-medicine Technology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Shanghai Unicar-Therapy Bio-medicine Technology's valuation, stock price, and market status.
Is Shanghai Unicar-Therapy Bio-medicine Technology a public or private company?
Shanghai Unicar-Therapy Bio-medicine Technology is a private company.
What is the current stock price of Shanghai Unicar-Therapy Bio-medicine Technology?
Shanghai Unicar-Therapy Bio-medicine Technology is a private company with no public stock price. Caplight tracks Shanghai Unicar-Therapy Bio-medicine Technology's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Shanghai Unicar-Therapy Bio-medicine Technology worth (valuation)?
Valuation information for Shanghai Unicar-Therapy Bio-medicine Technology is not publicly available.
Can I buy Shanghai Unicar-Therapy Bio-medicine Technology stock?
Shanghai Unicar-Therapy Bio-medicine Technology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Shanghai Unicar-Therapy Bio-medicine Technology's last funding round?
Shanghai Unicar-Therapy Bio-medicine Technology's most recent funding round was Series C on August 26, 2022.
Who are the main investors in Shanghai Unicar-Therapy Bio-medicine Technology?
Key investors in Shanghai Unicar-Therapy Bio-medicine Technology include Alwin Capital, Junci Investment, Apricot Capital.
Will Shanghai Unicar-Therapy Bio-medicine Technology IPO soon?
No public IPO plans have been announced for Shanghai Unicar-Therapy Bio-medicine Technology.
How can I track Shanghai Unicar-Therapy Bio-medicine Technology secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Shanghai Unicar-Therapy Bio-medicine Technology's secondary market activity and sign up for updates.